Volz T - Search Results

1

The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus.

Volz T, Allweiss L, Ben MBarek M, Warlich M, Lohse AW, Pollok JM, Alexandrov A, Urban S, Petersen J, Lütgehetmann M, Dandri M. Volz T, et al. J Hepatol. 2013 May;58(5):861-7. doi: 10.1016/j.jhep.2012.12.008. Epub 2012 Dec 13. J Hepatol. 2013. PMID: 23246506

2

Animal models for the study of HBV replication and its variants.

Dandri M, Volz TK, Lütgehetmann M, Petersen J. Dandri M, et al. Among authors: volz tk. J Clin Virol. 2005 Dec;34 Suppl 1:S54-62. doi: 10.1016/s1386-6532(05)80011-3. J Clin Virol. 2005. PMID: 16461225 Review.

3

Small animal model systems for studying hepatitis B virus replication and pathogenesis.

Dandri M, Lutgehetmann M, Volz T, Petersen J. Dandri M, et al. Among authors: volz t. Semin Liver Dis. 2006 May;26(2):181-91. doi: 10.1055/s-2006-939760. Semin Liver Dis. 2006. PMID: 16673296 Review.

4

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B.

Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, Longerich T, Schirmacher P, Metzler F, Zankel M, Fischer C, Currie G, Brosgart C, Petersen J. Wursthorn K, et al. Among authors: volz t. Hepatology. 2006 Sep;44(3):675-84. doi: 10.1002/hep.21282. Hepatology. 2006. PMID: 16941693

5

Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.

Volz T, Lutgehetmann M, Wachtler P, Jacob A, Quaas A, Murray JM, Dandri M, Petersen J. Volz T, et al. Gastroenterology. 2007 Sep;133(3):843-52. doi: 10.1053/j.gastro.2007.06.057. Epub 2007 Jul 3. Gastroenterology. 2007. PMID: 17854594

6

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

Petersen J, Dandri M, Mier W, Lütgehetmann M, Volz T, von Weizsäcker F, Haberkorn U, Fischer L, Pollok JM, Erbes B, Seitz S, Urban S. Petersen J, et al. Among authors: volz t. Nat Biotechnol. 2008 Mar;26(3):335-41. doi: 10.1038/nbt1389. Epub 2008 Feb 24. Nat Biotechnol. 2008. PMID: 18297057

7

Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia.

Dandri M, Murray JM, Lutgehetmann M, Volz T, Lohse AW, Petersen J. Dandri M, et al. Among authors: volz t. Hepatology. 2008 Oct;48(4):1079-86. doi: 10.1002/hep.22469. Hepatology. 2008. PMID: 18697217

8

In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.

Lutgehetmann M, Volz T, Köpke A, Broja T, Tigges E, Lohse AW, Fuchs E, Murray JM, Petersen J, Dandri M. Lutgehetmann M, et al. Among authors: volz t. Hepatology. 2010 Jul;52(1):16-24. doi: 10.1002/hep.23611. Hepatology. 2010. PMID: 20578126

9

[Knowledge about HBV, prevention behaviour and treatment adherence of patients with chronic hepatitis B in a large referral centre in Germany].

Lutgehetmann M, Meyer F, Volz T, Lohse AW, Fischer C, Dandri M, Petersen J. Lutgehetmann M, et al. Among authors: volz t. Z Gastroenterol. 2010 Sep;48(9):1126-32. doi: 10.1055/s-0029-1245304. Epub 2010 Sep 13. Z Gastroenterol. 2010. PMID: 20839162 German.

10

Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.

Lütgehetmann M, Bornscheuer T, Volz T, Allweiss L, Bockmann JH, Pollok JM, Lohse AW, Petersen J, Dandri M. Lütgehetmann M, et al. Among authors: volz t. Gastroenterology. 2011 Jun;140(7):2074-83, 2083.e1-2. doi: 10.1053/j.gastro.2011.02.057. Epub 2011 Mar 2. Gastroenterology. 2011. PMID: 21376046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters